Real4Reg

🚀 We’re excited to announce that the #Real4Reg project is now on Bluesky! Follow us to join the conversation and stay informed on our progress. 📲 bsky.app/profile/real4r…

As part of the #MetReal cluster, we joined the Multi-Stakeholder Workshop on RWD in regulatory & HTA decision-making in Bonn! Organized by @Real4Reg, the event brought together key stakeholders to advance #RWD use in Europe.💡 🔗 Read more: reddie-diabetes.eu/news/multi-sta…

#RealWorldData #RWE #Innovation #Healthcare #Regulatory #Science #MetReal

We are truly grateful for all the insightful discussions and valuable input we received. The energy and engagement from all participants is shaping the future of healthcare decision-making.

Multi-Stakeholder Workshop on RWD in regulatory & HTA decision-making in Bonn! We had a very fruitful hybrid workshop at the @bfarm_de in Bonn on 6 February 2025, bringing together a diverse group of stakeholders.

Real4Reg Partners’ Participation in Key Events: A Brief Recap of 2024 💡 As 2025 begins, it’s the perfect time to reflect on the key events that shaped #Real4Reg in 2024. Check out the full article on our website to learn more about our journey! real4reg.eu/news-events/ne…

Martin Russek presented a study evaluating the feasibility of supplementing single-arm trials with external control arms based on German #RWD sources. We are delighted that his poster was awarded 1st place in the poster price recognizing the importance of his work.

#Real4Reg members participated in the GAA’s 31st Annual Meeting, held from 21-22 November 2024 at @bfarm_de in Bonn. At the opening ceremony, the President of the @bfarm_de Prof. Dr. Karl Broich, briefly highlighted Real4Reg in the context of the #MetReal cluster.

🔬31st Annual Meeting of the German Drug Utilitsation Research Group (GAA e.V. - Gesellschaft für Arzneimittelanwendungsforschung und Arzneimitteltherapie): Real4Reg informs about feasibility of #RWD-based external control arms for single-arm trials.

In our September newsletter, we took a deep dive into the challenges of causal inference in Real-World Data (#RWD) analysis, exploring how Causal Machine Learning (#ML) can enhance the RWD analysis toolbox. At Real4Reg, we are applying these techniques to different tasks.

We are grateful for the opportunity to learn from such distinguished speakers, and the discussions that followed provided valuable perspectives to shape the future of the project!

Two invited talks were presented: 🎤 Andreas Kremer (Information Technology for Translational Medicine) gave a talk on #OMOP-CDM 🎤 Zaide Frias (@EMA_News) gave a talk on the EU Network Training Centre (EU-NTC).

🚀 Today, November 12, we held the last Consortium Meeting of 2024! As we are about to conclude the second year of the #Real4Reg project, this meeting brought together our project partners for a day of productive in-depth discussions.

Second Event: Demystifying Real-World Data – Insights for Patients 🕒 Time: 11:30–13:00 (CEST) 🔗 Register here: docs.google.com/forms/d/1WcWih…

First Event: Insights into Stakeholder Needs 🕒 Time: 09:30–11:00 (CEST) 🔗 Register here: docs.google.com/forms/d/1lW02T…

Reminder: Join Us for the Real4Reg 2024 Workshops! We’re thrilled to remind you about our two upcoming workshops focused on the evolving world of Real-World Data (RWD) and Real-World Evidence (RWE), designed for both professionals and patients! real4reg.eu/news-events/ne…